Matches 1 - 50 out of 201 1 2 3 4 5 >

AcclaimIP-ad

Match Document Document Title
US20140010823 METHOD FOR DETERMINING OPTIMUM INTRAOCULAR LOCATIONS FOR DRUG DELIVERY SYSTEMS  
A method for determining the optimum location for placement of an intraocular implant containing used to treat an ocular condition, particularly implants comprised of a biodegradable polymer and a...
US20100331290 TAXANE DELIVERY SYSTEM  
Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.
US20120214776 TOPICAL FORMULATIONS COMPRISING A STEROID  
The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or...
US20120142651 METHOD OF TREATMENT OF ALLERGIC RHINITIS  
There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous...
US20100311706 METHOD OF TREATMENT OF ALLERGIC RHINITIS  
There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous...
US20130243830 Stable Corticosteroid Nanoparticulate Formulations and Methods for the Making and Use thereof  
Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof  
Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
US20120101052 15-THIA STEROID COMPOUNDS AND COMPOSITIONS  
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the...
US20110218162 15-THIA STEROID COMPOUNDS AND COMPOSITIONS  
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the...
US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders  
Methods for treatment of ocular disorders using steroids modulate the effects of local and systemic hypoxic events mediated by hypoxia inducible factor-1 (HIF-1). Steroids that are useful as HIF-1...
US20100317638 Neuroactive 13,24-Cyclo-18,21-Dinorcholanes and Structurally Related Pentacylic Steroids  
Novel pentacyclic steroids and pentacyclic D-homosteroids comprising: (i) the tetracyclic steroid ring system or tetracyclic D-homosteroid ring system, respectively; (ii) a C(3) substituent...
US20120065178 OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES  
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which,...
US20140199297 TRITERPENE GLYCOSIDE AND TRITERPENE COMPOSITIONS AND METHODS OF USING SAME  
In the present invention, different strategies are used to improve the bioavailability of triterpene glycosides and triterpenes including, for example, (a) a covalent approach involving...
US20110171307 METHODS AND PRODUCTS FOR TREATMENT OF DISEASES  
The present invention relates to the treatment of diseases and conditions with an effective amount of a steroid having those formulas given in the specification, or a pharmacologically-acceptable...
US20110275587 TOPICAL DELIVERY OF VISCOUS MEDICATIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CHRONIC SINUSITIS  
A medication or combination of medications for the treatment of a disease involving the sinuses is incorporated into a sterile medical gel. The viscosity of the gel or the adhesion of the gel to...
US20120065177 PHARMACEUTICAL FORMULATIONS COMPRISING AZELASTINE AND A CORTICOSTEROID FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS  
The present invention relates to method for the treatment of allergic rhinitis comprising: administrating to a patient in need thereof a pharmaceutical formulation comprising a compound for...
US20120101077 AGGLOMERATE FORMULATIONS USEFUL IN DRY POWDER INHALERS  
Several embodiments of the present invention provide for an agglomerate useful for an agglomerate based dry powder inhaler comprising at least one active pharmaceutical agent, at least one...
US20110200647 PULMONARY DISEASE TREATMENT  
The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of...
US20120040944 MEDICINAL CREAM MADE USING MOMETASONE FUROATE AND CHITOSAN AND A PROCESS TO MAKE THE SAME  
The present invention relates to a composition for treating skin inflammation, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a...
US20150165036 INHALATION COMPOSITIONS COMPRISING GLUCOSE ANHYDROUS  
The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and...
US20100317637 ANTI-HEPATITIS C COMPOSITION AND METHOD FOR PREPARING DRUG FOR INHIBITING HEPATITIS C VIRUSES OR TREATING HEPATITIS C  
The invention provides an anti-hepatitis C composition including: an effective amount of limonoid compound, wherein the structure of the limonoid compound is shown as Structure (I): where R1...
US20150209429 CORTICOSTEROID COMPOSITIONS  
The present disclosure generally relates to pharmaceutical corticosteroid compositions, and methods of making the same.
US20140357607 CORTICOSTEROID COMPOSITIONS  
The present disclosure generally relates to pharmaceutical corticosteroid compositions, and methods of making the same.
US20130156828 Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same  
A drug product comprises a dry powder inhalation device having a pharmaceutical composition present therein, said pharmaceutical composition comprising a compound which is (6α, 11β, 16α,...
US20150165037 INHALATION COMPOSITIONS COMPRISING CORTICOSTEROID AND SORBITOL  
The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and...
US20150099712 METHOD AND COMPOUNDS FOR INHIBITING THE MCM COMPLEX AND THEIR APPLICATION IN CANCER TREATMENT  
A method for treating cancer by using an agent which is capable of inhibiting the functionality of the MCM complex, a heterohexameric ring formed from six subunits, in the process of DNA...
US20100179115 USE OF A GLUCOCORTICOID RECEPTOR II ANTAGONIST TO TREAT DEPRESSION IN PATIENTS TAKING IL-2  
The invention pertains to the discovery that type II glucocorticoid receptor antagonists can be used in methods for reversing or inhibiting the symptoms of depression in patients receiving...
US20140135302 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BIOMARKERS AND USES THEREOF  
Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided....
US20060058274 Use of an aldosterone receptor antagonist to improve cognitive function  
Aldosterone receptor antagonists for the prevention and treatment of cognitive dysfunction are disclosed.
US20100298280 Compounds for the Modulation of Huntingtin Aggregation, Methods and Means for Identifying Such Compounds  
The present invention relates to tetranortriterpenoid compounds and pharmaceutical compositions thereof, which are provided for use in the treatment, diagnosis and/or prevention of trinucleotide...
US20080279948 Treatment of Asthma and Copd Using Triple-Combination Therapy  
A medicament comprising, separately or together (A) a compound of formula I in free or salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the...
US20130295100 MARKERS FOR ACUTE KIDNEY INJURY AND USES THEREOF  
The present invention relates to a method for predicting the risk of developing acute kidney injury in a subject from which a biological sample is obtained comprising: detecting the presence of at...
US20120134935 USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE  
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of...
US20150224197 INHALATION COMPOSITIONS  
The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and...
US20130115293 Therapeutic Polymeric Nanoparticles Comprising Corticosteroids and Methods of Making and Using Same  
The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 0.1 to about 50 weight percent of a corticosteroid; and about 50...
US20070122843 Isoflavonoid analogs and their metal complexes as anti-cancer agents  
A pharmacologic agent for treating and/or preventing cancer, among other diseases and conditions, and particularly breast, prostate, and pancreatic cancer, in humans and animals. The novel...
US20100305079 Method of Treating Human Preeclampsia Employing Resibufagenin  
A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of...
US20070265236 Asthma Treatment Methods  
The invention relates to the use of compounds to ameliorate or treat an condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used...
US20130184244 PROCESS FOR PREPARING DELTA-7,9(11) STEROIDS FROM GANODERMA LUCIDUM AND ANALOGS THEREOF  
Processes for preparing lanostane triterpenes from the medicinal mushroom Ganoderma lucidum, and related compounds are described. Compounds, compositions, and methods for treating cancer are also...
US20130274215 PHARMACEUTICAL COMPOSITIONS TO TREAT FIBROSIS  
The present invention provides methods for the prevention, treatment and/or amelioration of fibrosis or fibrotic conditions. The present invention further provides small molecule inhibitors of...
US20140228332 METHOD FOR ENHANCING THE SECRETION OF GLP-1 USING BITTER COMPOUNDS  
The present invention provides a method for enhancing the secretion of GLP-1 of the intestinal endocrine L-cells using a bitter compound, wherein the bitter compound is a cucurbitane-triterpenoid...
US20120301439 INHIBITION OF CHOROIDAL NEOVASCULARIZATION  
Methods of treatment of diseases that include or are characterized by inappropriate or pathological neovascularization are disclosed. These diseases include diseases of the eye, such as diabetic...
US20120184519 Compositions and Methods for Preventing or Treating Influenza Virus Infection  
The invention includes compositions and methods for regulating PI3K p110 delta as an anti-retroviral therapy. The invention includes inhibiting p110 delta, a component of PI3K p110 delta signaling...
US20120263660 Hair Loss Treatment  
This invention relates to the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the prevention or treatment of stress induced hair loss.
US20140206749 Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases  
The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
US20080261928 Method of Treating Human Preeclampsia Employing Resibufagenin  
A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of...
US20090258040 STEROID TREATMENT FOR HOT FLASHES  
Embodiments of the invention relate to methods for treating individuals suffering from hot flashes by vomeronasally administering a therapeutically effective dosage of a steroid agent. The hot...
US20110305719 Inhibition of Pro-Inflammatory Cytokine Induced Response  
Method and compositions for reducing the inflammation after cytokine exposure of an islet cell transplant without affecting the viability and potency are disclosed herein. The present invention...
US20080107609 PULMONARY DISEASE TREATMENT  
The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of...
US20130150311 MIXED POLOXAMER EXCIPIENTS  
In one aspect, the present invention is directed to a dry, flowable and compressible composition, useful as a pharmaceutical excipient, which composition comprises a mixture of hydrophobic and...
Matches 1 - 50 out of 201 1 2 3 4 5 >